Nuzenio

First Gene Therapy

First Gene Therapy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 4 publisher sources 100/100 entity strength

Latest news

First human trial of gene-silencing therapy launched to treat vision-threatening effects of Bardet-Biedl syndrome - Ophthalmology Times EuropeOphthalmology Times Europe · Fri, 07 Aug 2026 11:06:32 GMT First-in-Human Gene Editing Trial: What Went Wrong? - MedscapeMedscape · Tue, 04 Aug 2026 10:11:09 GMT 2019 Kolon Life Science, the glory of the country’s first gene therapy... but the ingredients were different [That Stock Back Then] - theconnectmoney.comtheconnectmoney.com · Mon, 03 Aug 2026 23:49:00 GMT 2019 Kolon Life Science’s brief glory for Korea’s first gene therapy…then the company’s “ingredient” story differed [That Stock at That Time] - theconnectmoney.comtheconnectmoney.com · Mon, 03 Aug 2026 23:49:00 GMT World's First Gene Therapy for 2-Year-Old Children | Root-Cause Intervention for Early Childhood Hematological Diseases - 36 Kr36 Kr · Fri, 31 Jul 2026 01:05:02 GMT

Timeline

Fri, 07 Aug 2026 11:06:32 GMTFirst human trial of gene-silencing therapy launched to treat vision-threatening effects of Bardet-Biedl syndrome - Ophthalmology Times Europe

Tue, 04 Aug 2026 10:11:09 GMTFirst-in-Human Gene Editing Trial: What Went Wrong? - Medscape

Mon, 03 Aug 2026 23:49:00 GMT2019 Kolon Life Science, the glory of the country’s first gene therapy... but the ingredients were different [That Stock Back Then] - theconnectmoney.com

Mon, 03 Aug 2026 23:49:00 GMT2019 Kolon Life Science’s brief glory for Korea’s first gene therapy…then the company’s “ingredient” story differed [That Stock at That Time] - theconnectmoney.com

Fri, 31 Jul 2026 01:05:02 GMTWorld's First Gene Therapy for 2-Year-Old Children | Root-Cause Intervention for Early Childhood Hematological Diseases - 36 Kr

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Kolon Life Science4 live mentions First3 live mentions Ophthalmology Times Europe3 live mentions Bardet2 live mentions Biedl2 live mentions Human Gene Editing2 live mentions Trial2 live mentions What Went Wrong2 live mentions That Stock Back2 live mentions Then2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Gene Therapy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.